FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

372580007: Bronchodilator (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1197874017 Bronchodilator (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1211109010 Bronchodilator en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
1197874017 Bronchodilator (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
1197874017 Bronchodilator (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1211109010 Bronchodilator en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
1211109010 Bronchodilator en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
191731000077112 bronchodilatateur fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
191731000077112 bronchodilatateur fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

82 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Bronchodilator Is a Respiratory system agent (substance) true Inferred relationship Existential restriction modifier (core metadata concept)
Inbound Relationships Type Active Source Characteristic Refinability Group
Guaifenesin 1 g oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely guaifenesin 675 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Guaifenesin 575 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Guaifenesin 200 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Fluticasone propionate 220mcg/actn aerosol The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Fluticasone propionate 110mcg (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Fluticasone propionate 250mcg/spr inhalant The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Fluticasone propionate 110mcg/actn aerosol The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Fluticasone propionate 44mcg/actn aerosol The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Fluticasone propionate 50mcg/spr inhalant The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Fluticasone propionate 125mcg/spr inhalant The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Fluticasone propionate 0.05% spray The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Fluticasone propionate 9g spray The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Fluticasone propionate 50mcg/spray spray The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Brompheniramine maleate + guaifenesin + hydrocodone bitartrate 2mg/200mg/5mg syrup The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Dyphylline + guaifenesin 100mg/100mg elixir The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Dyphylline + guaifenesin 100mg/100mg liquid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Dyphylline + guaifenesin 100mg/100mg syrup The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely diprophylline 100 milligram and guaifenesin 100 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Dyphylline + guaifenesin 100mg/50mg syrup The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Dyphylline + guaifenesin 200mg/100mg capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Diprophylline 200 mg and guaifenesin 200 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Fluticasone propionate + salmeterol xinafoate 100mcg/50mcg powder for oral inhalation (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Guaifenesin 600mg m/r tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Product containing diprophylline (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Product containing guaifenesin (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Product containing diprophylline in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Parenteral dyphylline The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Dyphylline+guaifenesin 100mg/100mg liquid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Guaifenesin 100mg/5ml syrup The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Siltussin sa 100mg/5ml syrup The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Guaifenesin 100 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Guaifenesin 1200mg m/r tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Guaifenesin 200 mg oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Guaifenesin 300mg m/r capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Guaifenesin 600mg m/r capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Product containing aspirin and butalbital and caffeine and codeine phosphate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Diprophylline- and guaifenesin-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Product containing aspirin and caffeine and propoxyphene hydrochloride The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Product containing aspirin and caffeine and dihydrocodeine tartrate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Caffeine + ergotamine tartrate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Caffeine- and sodium benzoate-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Product containing butalbital and caffeine and paracetamol (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Aspirin + caffeine + orphenadrine citrate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Product containing butalbital and caffeine and codeine phosphate and paracetamol The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Product containing aspirin and butalbital and caffeine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely caffeine 100 milligram and ergotamine tartrate 1 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Ergotamine tartrate+caffeine 2mg/100mg suppository (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Adverse reaction caused by antiasthmatic (disorder) Causative agent (attribute) False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Product containing caffeine and dihydrocodeine tartrate and paracetamol The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Adverse reaction to antiasthmatic NOS Causative agent (attribute) False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Product containing tiotropium (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Tiotropium Is a True Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Respiratory sympathomimetic agent Is a False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Spirometry for bronchospasm with prolonged evaluation after bronchodilator Direct substance False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept) 1
Ephedrine hydrochloride 30mg/10mL injection (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Ephedrine hydrochloride 30mg/1mL injection (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
chlorhydrate d'éphédrine 3 mg/mL, seringue préremplie de 10 mL de solution pour injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Eformoterol The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Eformoterol fumarate 12micrograms inhalation capsules+inhaler (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Eformoterol fumarate dihydrate 6micrograms breath-actuated dry powder inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Eformoterol fumarate dihydrate 12micrograms breath-actuated dry powder inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Ephedrine hydrochloride 15 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Ephedrine hydrochloride 30 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Ephedrine hydrochloride 15mg/5mL elixir The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Ephedrine hydrochloride 4mg/5mL s/f mixture The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Bronchilator inhaler The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Bronchodilators + sedative The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Menthol 35.55mg inhalant capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely antazoline sulfate 5 milligram/1 milliliter and xylometazoline hydrochloride 500 microgram/1 milliliter conventional release eye drops (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely ephedrine hydrochloride 5 milligram/1 milliliter conventional release nasal drops (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Ephedrine hydrochloride 10 mg/mL nasal drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Oxymetazoline hydrochloride 500 microgram/mL nasal spray The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely xylometazoline hydrochloride 1 milligram/1 milliliter conventional release nasal drops (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Xylometazoline hydrochloride 0.05% pediatric nasal drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Product containing tulobuterol (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Sympathomimetic compound (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Ergot compound The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Xylometazoline hydrochloride 1 mg/mL nasal spray The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Inhaled bronchodilator therapy Direct substance False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept) 1
Ephedrine hydrochloride (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Product containing ephedrine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Xylometazoline-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Medicinal product acting as decongestant (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Nasal decongestant preparation The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Tulobuterol hydrochloride The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Ephedrine hydrochloride [respiratory use] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Ephedrine HCl [enuresis] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Product containing dextromethorphan and guaifenesin (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Guaifenesin 600mg m/r/dextromethorphan 30mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Guaifenesin 1200mg m/r/dextromethorphan 60mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Product containing guaifenesin and hydrocodone (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Product containing codeine and guaifenesin (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Chlorphenamine- and ephedrine- and pentoxyverine- and phenylephrine-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Ephedrine hydrochloride [nose] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Phenylephrine hydrochloride [nose] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Xylometazoline nasal solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Product containing guaifenesin and phenylephrine and phenylpropanolamine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Product containing guaifenesin and phenylephrine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)
Product containing dextromethorphan and guaifenesin and phenylpropanolamine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Bronchodilator Inferred relationship Existential restriction modifier (core metadata concept)

Start Page 2 of 3 End

This concept is not in any reference sets

Back to Start